Compare Nutanix Inc (NTNX) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nutanix Inc vs Regeneron Pharmaceuticals Inc — how do they compare? Nutanix Inc trades at $54 (market cap $14.90B), while Regeneron Pharmaceuticals Inc trades at $673.67 (market cap $70.47B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 4.7× Nutanix Inc's market cap, and Regeneron Pharmaceuticals Inc pays a 0.56% dividend while Nutanix Inc pays none. Which is the better fit depends on your goals.
| NTNX | REGN | |
|---|---|---|
Market Cap | $14.90B | $70.47B |
Sector | Technology | Health |
52-Week High | $81.12 | $812.27 |
52-Week Low | $34.41 | $545.46 |
Enterprise Value | $14.41B | $64.42B |
Dividend Yield | — | 0.56% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nutanix Inc
Nutanix, Inc. is a global leader in cloud software and hyperconverged infrastructure (HCI) solutions. The company's platform converges computing, virtualization, and storage into a single, seamless software-defined solution, enabling private, hybrid, and multi-cloud environments. Nutanix helps organizations simplify data center operations, manage their applications across various cloud platforms, and reduce IT complexity, positioning it as a key enabler of modern hybrid cloud strategies.
Read more on NTNX →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
